These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date 2004-002280-24 THERAPEUTIC AND BIOLOGICAL EFFECTS OF IMATINIB MESYLATE (STI571) IN PRIMARY HYPERESINOPHILIC SYNDROME (HES), CHRONIC EOSINOPHILIC LEUKEMIA (CEL) AND CHRONIC IDIOPHATIC HYPEREOSINOPHILIA (CIH): A STUDY... bad-data
Completed, but no date 2004-004082-15 A PHASE II CLINICAL STUDY TO DETERMINE THE EFFICACY AND SAFETY OF DEPOCITE (CITARABINE LIPOSOMIALE INJECTON) FOR THE TREATMENT OF CNS RELAPSE IN ADULT PATIENTS WITH ACUTE LYMPOBLASTIC LEUKEMIA OR VERY... bad-data
Completed, but no date 2004-004141-18 STUDY RANDOMIZED, CONTROLLED, DOUBLE BLIND, PHASE III, TO CONFRONTED LEVOBUPIVACAINA 0.2 , LEVOBUPIVACAINE 0.15 KETAMINE S 0.5 MG/KG AND LEVOBUPIVACAINA 0.125 KETAMINE S 0.5 MG/KG bad-data
Completed, but no date Terminated 2005-000699-41 Multicentric Pilot Phase II Study for use of Fludarabine plus Cyclophosphamide Followed by 90 Y-Ibritumomab Tiuxetan Zevalin in the Treatment of non-Follicular Indolent Lymphomas Refractory or Relap... bad-data
Not reported 2005-000700-14 MULTI-CENTRE, RANDOMISED, PHASE III TRIAL COMPARING HIGH DOSE SEQUENTIAL CHEMOTHERAPY hds WITH RITUXIMAB AND AUTOLOGOUS PERIPHERAL BLOOD PROGENITUR ALL TRANSPLANTION VERSUS 2- WEEKLY CHOP WITH RITUX... 2013-07-29 due-trials
Completed, but no date 2005-000805-68 A RANDOMISED STUDY TO COMPARE THE REDUCED INTENSIVE REGIMEN CONTAINING ALEMTUZUMAB VERSUS ATG IN ALLOGENIC TRAPIANTS FROM MUD bad-data
Completed, but no date 2005-001164-32 A RANDOMIZED STUDY, POSPECTIVE, ON THREE DIFFERENT STRATEGY OF HIV POSITIVE NAIVE FOR THE ANTIRETROVIRAL THERAPY bad-data
Completed, but no date 2005-004025-26 THERAPEUTIC SIMPLIFICATION WITH THYMIDINE ANALOGUR SPARING REGIMENS IN PATIENTS ON EFFECTIVE HAART: A CONTROLLED, RANDOMIZED STUDY bad-data
Ongoing 2005-004449-32 EFFECTIVENESS OF THE LEVOSIMENDAN IN THE THERAPY OF DIASTOLIC DYSFUNCTION OF CARDIAC SURGERY not-yet-due
Completed, but no date 2005-004479-38 Effects of the association remifentanil-propofol in TCI on the respiratory exchanges: comparison between controlled and spontaneous ventilation bad-data
Ongoing 2005-004809-29 The steady state pharmacokinetics (PK) of atazanavir boosted with ritonavir during pregnancy and postpartum in HIV-1 infected pregnant women not-yet-due
Ongoing 2006-002786-39 A PROSPECTIVE TRIAL , MONOCENTRIC, RANDOMIZED, TO EVALUATE THE RENAL'S FUNCTION IN SUBJECTS WITH CARDIAC TRANSPLANTED not-yet-due
Ongoing 2006-002805-30 Strategic long term, immunologically driven treatment interruptions in previously naive patients starting HAART: a controlled, randomized, multicenter study not-yet-due
Completed, but no date 2006-003817-42 A phase III trial in adult acute myelogenous leukemia AML comparing 1 standard-dose versus high-dose remission induction therapy and 2 , within a risk-oriented postremission strategy, an autologou... bad-data
Completed, but no date 2006-006247-31 TIPRANAVIR MONOTHERAPY IN EXPERIENCED PATIENTS WITH MULTIPLE REVERSE TRANSCRIPTASE MUTATIONS A PROOF-OF-CONCEPT STUDY bad-data
Ongoing 2007-001413-42 Study of Fludarabine based conditioning for Allogeneic Stem cell Transplantation for Myelofibrosis not-yet-due
Completed, but no date 2007-007839-33 Adherence to a one pill, once-a-day antiretroviral regimen bad-data
Completed, but no date 2008-001881-10 Raltegravir/Atazanavir pharmacokinetics and evaluation of lipids bad-data
Ongoing 2008-003185-26 Sequential Infusion of Unmanipulated Donor Lymphocytes and Cytokine Induced Killer (CIK) cells after allogeneic stem cell transplantation not-yet-due
Exempt 2008-006862-27 Infusion of Cytokine Induced Killer (CIK) cells in patients relapsing after allogeneic stem cell transplantation not-yet-due
Exempt Terminated 2009-012350-20 MESENCHYMAL STEM CELLS UNDER BASILIXIMAB/ LOW DOSE RATG TO INDUCE RENAL TRANSPLANT TOLERANCE Infusione di cellule mesenchimali staminali espanse ex-vivo per indurre tolleranza immunologica donator... 2013-07-18 not-yet-due
Completed, but no date 2009-014656-30 Combination of Atazanavir and Raltegravir as Dual Strategy bad-data
Ongoing 2010-019518-25 (Maraviroc ENHancement of Immunological Response): A pilot study of maraviroc as an add-on in patients with reduced CD4 cell count despite full viral suppression not-yet-due
Ongoing 2011-002977-44 Antibiotics vs Surgery in Acute Appendicitis: an intention to treat prospective randomised controlled study, The ASAA-Study Antibiotics vs Surgery in Acute Appendicitis: an intention to treat prosp... not-yet-due
Not reported 2012-002616-22 Stage IIIC unresectable epithelial ovarian/tubal cancer with partial or complete response after 1st line neoadjuvant chemotherapy (3 cycles CBDCA+Paclitaxel): a phase 3 prospective randomized study ... 2020-12-30 due-trials
Ongoing 2013-002573-22 PROBE TRIAL (Pilot Rilpivirine Observational Evaluation) Monocenter, national, prospective, open label, pilot, proof-of-concept study on the use of rilpivirine as substitutive agent for the HAART nucl... not-yet-due
Ongoing 2014-002317-32 An Open-Label Study to Explore the Clinical Efficacy of GS 7977 (Sofosbuvir -Sovaldi®) with Ribavirin as Pre-Emptive Administration in Transplant-Recipients with Hepatitis C Virus (HCV) active infecti... not-yet-due
Ongoing 2014-005197-11 Sugammadex and neurogical effects central SUGAMMADEX ED EFFETTI NEUROLOGICI CENTRALI not-yet-due
Ongoing 2014-005474-11 Pilot clinical study multicenter, prospective, randomized, open, non-profit to evaluate the efficacy of progesterone administered with different dose subcutaneously compared to progesterone administer... not-yet-due
Completed, but no date, and reported results Terminated 2015-003884-12 A pilot, prospective, randomized, open-label, blinded endpoint (PROBE) histopathology trial to assess the effects of ACE- inhibition therapy on glomerular proliferative lesions in patients with extrac... bad-data
Ongoing 2016-003948-36 Multicenter, national, prospective, open label, randomized, pilot, proof-of-concept study on the use of rilpivirine plus Darunavir/cobicistat as substitutive agents in virologic suppressed patients ... not-yet-due